[1] SUNG H, FERLAY J, SIEGEL R L, et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2021, 71(3):209-249.
[2] ZOCHIOS V, UMAR I, SIMPSON N, et al.Peripherally inserted central catheter(PICC)-related thrombosis in critically ill patients[J].J Vasc Access, 2014, 15(5):329-337.
[3] WANG G R, LI Y F, WU C L, et al.The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients[J].Medicine(Baltimore), 2020, 99(12):e19409.
[4] 田婷, 黄锐娜, 戚熠, 等.肿瘤患者PICC置管相关静脉血栓形成危险因素Meta分析[J].护理学报, 2019, 26(11):49-54.
[5] LUO L, JING X M, WANG G R, et al.Peripherally inserted central catheter-related upper extremity venous thrombosis in oncology patients[J].J Ultrasound Med, 2016, 35(8):1759-1763.
[6] KANG J R, CHEN W, SUN W Y, et al.Peripherally inserted central catheter-related complications in cancer patients:a prospective study of over 50, 000 catheter days[J].J Vasc Access, 2017, 18(2):153-157.
[7] CHOPRA V, ANAND S, HICKNER A, et al.Risk of venous thromboembolism associated with peripherally inserted central catheters:a systematic review and meta-analysis[J].Lancet, 2013, 382(9889):311-325.
[8] JONES D, WISMAYER K, BOZAS G, et al.The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients[J].Thromb J, 2017, 15(1):25.
[9] MOONS K G M, DE GROOT J A, BOUWMEESTER W, et al.Critical appraisal and data extraction for systematic reviews of prediction modelling studies:the CHARMS checklist[J].PLoS Med, 2014, 11(10):e1001744.
[10] WOLFF R F, MOONS K G M, RILEY R D, et al.PROBAST:a tool to assess the risk of bias and applicability of prediction model studies[J].Ann Intern Med, 2019, 170(1):51-58.
[11] MOONS K G M, WOLFF R F, RILEY R D, et al.PROBAST:a tool to assess risk of bias and applicability of prediction model studies:explanation and elaboration[J].Ann Intern Med, 2019, 170(1):W1-W33.
[12] 陈香萍, 张奕, 庄一渝, 等.PROBAST:诊断或预后多因素预测模型研究偏倚风险的评估工具[J].中国循证医学杂志, 2020, 20(6):737-744.
[13] 陈茹, 王胜锋, 周家琛, 等.预测模型研究的偏倚风险和适用性评估工具解读[J].中华流行病学杂志, 41(5):776-781.
[14] 董鲜桃, 张永杰, 朱姝, 等.肺癌化疗患者经外周静脉穿刺的中心静脉导管置管后发生上肢深静脉血栓的危险因素及其风险预测列线图模型构建[J].实用心脑肺血管病杂志, 2022, 30(8):8-12.
[15] 高利琴, 赵林芳, 杨方英, 等.肺癌患者PICC相关性静脉血栓的风险预测列线图模型构建与评价[J].护理与康复, 2022, 21(5):6-12.
[16] 周纪云, 王爱红, 卢菲, 等.血液系统恶性肿瘤病人PICC相关性血栓风险预测模型的构建[J].护理研究, 2022, 36(10):1758-1763.
[17] FU J Q, CAI W F, ZENG B W, et al.Development and validation of a predictive model for peripherally inserted central catheter-related thrombosis in breast cancer patients based on artificial neural network:a prospective cohort study[J].Int J Nurs Stud, 2022, 135:104341.
[18] PENG S Y, WEI T, LI X Y, et al.A model to assess the risk of peripherally inserted central venous catheter-related thrombosis in patients with breast cancer:a retrospective cohort study[J].Support Care Cancer, 2022, 30(2):1127-1137.
[19] YUE J, ZHANG Y, XU F, et al.A clinical study of peripherally inserted central catheter-related venous thromboembolism in patients with hematological malignancies[J].Sci Rep, 2022, 12(1):9871.
[20] 孙玉萍, 宋岗, 张建美, 等.基于机器学习的PICC相关性上肢深静脉血栓形成预测[J].循证护理, 2021, 7(15):2071-2075.
[21] SONG X M, LU H, CHEN F, et al.A longitudinal observational retrospective study on risk factors and predictive model of PICC associated thrombosis in cancer patients[J].Sci Rep, 2020, 10(1):10090.
[22] 杨方英, 华荣誉, 吴婉英, 等.肿瘤患者外周静脉置入中心静脉导管相关性上肢静脉血栓风险预测列线图模型构建[J].肿瘤研究与临床, 2020, 32(7):456-461.
[23] LIU S S, ZHANG F Y, XIE L L, et al.Machine learning approaches for risk assessment of peripherally inserted central catheter-related vein thrombosis in hospitalized patients with cancer[J].Int J Med Inform, 2019, 129:175-183.
[24] 张昊, 谢欣, 周章剑, 等.列线图预测恶性肿瘤患者PICC导管相关血栓风险的研究[J].中国肿瘤临床, 2018, 45(3):137-141.
[25] 朱薇.肿瘤患者PICC导管相关性血栓形成风险评估表的构建[D].南宁:广西医科大学, 2018.
[26] MOONS K G M, ROYSTON P, VERGOUWE Y, et al.Prognosis and prognostic research:what, why, and how?[J].BMJ, 2009, 338:b375.
[27] MOONS K G M, KENGNE A P, WOODWARD M, et al.Risk prediction models:I.Development, internal validation, and assessing the incremental value of a new(bio)marker[J].Heart, 2012, 98(9):683-690.
[28] COWLEY L E, FAREWELL D M, MAGUIRE S, et al.Methodological standards for the development and evaluation of clinical prediction rules:a review of the literature[J].Diagn Progn Res, 2019, 3:16.
[29] HENDRIKSEN J M T, GEERSING G J, MOONS K G M, et al.Diagnostic and prognostic prediction models[J].J Thromb Haemost, 2013, 11:129-141.
[30] HEINZE G, DUNKLER D.Five myths about variable selection[J].Transpl Int, 2017, 30(1):6-10.
[31] VAN SMEDEN M, MOONS K G, DE GROOT J A, et al.Sample size for binary logistic prediction models:beyond events per variable criteria[J].Stat Methods Med Res, 2019, 28(8):2455-2474.
[32] RILEY R D, ENSOR J, SNELL K I E, et al.Calculating the sample size required for developing a clinical prediction model[J].BMJ, 2020, 368:m441.
[33] WYNANTS L, COLLINS G S, VAN CALSTER B.Key steps and common pitfalls in developing and validating risk models[J].BJOG, 2016, 124(3):423-432.
[34] 邓建新, 单路宝, 贺德强, 等.缺失数据的处理方法及其发展趋势[J].统计与决策, 2019, 35(23):28-34.
[35] COLLINS G S, OGUNDIMU E O, COOK J A, et al.Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model[J].Stat Med, 2016, 35(23):4124-4135.
[36] STEYERBERG E W, UNO H, IOANNIDIS J P A, et al.Poor performance of clinical prediction models:the harm of commonly applied methods[J].J Clin Epidemiol, 2018, 98:133-143.
[37] 吕梦颖, 卢大松, 李香梅, 等.不同锻炼方式预防老年肿瘤患者PICC相关性血栓的研究[J].现代医学, 2021, 49(1):64-68.
[38] VAN CALSTER B, VICKERS A J.Calibration of risk prediction models:impact on decision-analytic performance[J].Med Decis Making, 2015, 35(2):162-169. |